低氧习服大鼠骨骼肌毛细血管密度和血流供应的变化特点

目的：观察大鼠在低氧习服过程中,骨骼肌毛细血管密度和血流供应的变化规律。方法：大鼠在模拟海拔5000m低氧5、15和30d后,用肌球蛋白ATP酶（mATPase)组织化学方法显示骨骼肌Ⅰ、Ⅱ型纤维和毛细血管并进行图像分析;用放射性微球法测定骨骼肌血流量。结果：低氧5d组大鼠骨骼肌纤维即出现明显萎缩,15d和30d组大鼠毛细血管密度显著增高,但单位面积内毛细血管数/肌纤维数（C/F）的比值无明显变化。在所观测的时间内,各组大鼠骨骼肌血流量未见明显变化。结论：大鼠在低氧习服过程中,毛细血管并未发生真正的增生,而由于骨骼肌纤维出现萎缩,使毛细敌国管数目相对增多。     

混合甲醛固定液固定大肠癌淋巴结标本的最佳免疫组化效果研究

目的:探讨混合甲醛固定液固定大肠癌淋巴结标本的最佳免疫组化效果。方法:采用不同pH值(6.0、7.0、8.0)的混合甲醛固定液对39枚大肠癌淋巴结标本进行不同时间(6 h、6 h-12 h、1 d-7 d)的固定处理。以细胞角蛋白20(CK20)为目标抗原,运用OIympusdp 70图像采集分析仪抽选出混合甲醛固定液最佳免疫组化染色的pH值及固定时间。结果:经pH值为7.0混合甲醛固定液处理后,阳性率为92.31%,高于经pH值为6.0、8.0的混合甲醛固定液处理后的76.92%、74.36%,且经pH值为7.0、8.0处理后的阳性率比较有统计差异(P0.05)。混合甲醛固定液的固定时间在6 h-12 h时的阳性率为94.87%,高于固定时间为6 h、1 d-7 d处理的30.77%、76.92%(P0.05)。结论:对于大肠癌淋巴结标本,以CK20为目标抗原,选择pH值为7.0的混合甲醛固定液固定6 h-12 h能够得到质量较佳的免疫组化染色效果。     

不同抗原修复方法对肝癌组织中内源性生物素的影响及对策

目的探讨不同抗原修复方法对肝癌组织中内源性生物素的影响以及消除办法.方法采用pH6.0、pH8.0及pH9.0不同pH值的抗原修复液进行修复,对30例经甲醛固定石蜡包埋的肝细胞癌组织中内源性生物素活性进行检测,并通过不同检测方法对30例肝细胞癌中AFP(Alpha Fetoprotein)染色结果进行对比.结果加热抗原修复暴露肝细胞癌组织中内源性生物素的活性.不同pH值抗原修复液对内源性生物素的活性影响各不相同,阳性强度随着pH值增高而增强.生物素阻断剂能有效阻断内源性生物素的活性.采用pH9.0Tris-EDTA进行修复加Envision检测系统可提高肝癌组织中AFP的阳性率及阳性强度.结论加热抗原修复可使被甲醛封闭的内源性生物素的活性重新暴露,对免疫组化的染色结果造成影响,生物素阻断系统是消除内源性生物素的有效方法,采用pH9.0的抗原修复液进行修复加Envision非生物素检测系统是免疫组化染色中较为理想的检测方法.     

大鼠骨骼肌损伤后中性粒细胞、巨噬细胞和肌成纤维细胞数量分析研究

目的 研究大鼠骨骼肌损伤后中性粒细胞、巨噬细胞和肌成纤维细胞数量的变化情况,为今后骨骼肌损伤修复的病理学机制研究打下坚实的基础.方法 建立大鼠骨骼肌机械性损伤动物模型,随机分为伤后6h、12h、1d、3d、7d、10d、14d及正常对照组.应用免疫组织荧光染色和免疫组织化学染色,检测大鼠骨骼肌损伤后不同时间点中性粒细胞、巨噬细胞和肌成纤维细胞的数量.结果 伤后6h-12h,损伤区可见中性粒细胞和巨噬细胞浸润,中性粒细胞数量达到高峰.伤后1d,损伤区巨噬细胞数量急剧增加,迅速达到高峰,而中性粒细胞数量开始下降.伤后3d,中性粒细胞和巨噬细胞数量都显著下降.伤后7d,肌成纤维细胞开始出现.到伤后10d-14d,损伤区主要以肌成纤维细胞为主,偶见巨噬细胞.结论 大鼠骨骼肌损伤区中性粒细胞、巨噬细胞和肌成纤维细胞数量呈时间规律性变化,以期为骨骼肌损伤修复的病理学机制研究提供参考资料.     

TNFα对正常昆明小鼠骨骼肌和肝脏葡萄糖摄取的影响

目的观察肿瘤坏死因子α(TNFα)对正常昆明小鼠骨骼肌和肝脏葡萄糖摄取的影响。方法80只昆明小鼠随机分为高剂量连续注射组(TH组,n=20)、TNFα低剂量连续注射组(TL组,n=20)、TNFα高剂量一次注射组(T1组,n=20)和正常对照组(C组,n=20),以3H标记的2脱氧葡萄糖(2-DG)为示踪剂,观察各组非胰岛素刺激(基础)和胰岛素刺激的离体骨骼肌和肝脏葡萄糖摄取量的变化。结果1)正常昆明小鼠肝脏基础葡萄糖摄取量明显高于骨骼肌葡萄糖摄取量(P<0.01),肝脏胰岛素刺激的葡萄糖摄取量变化值明显低于骨骼肌葡萄糖摄取量变化值(P<0.01)。2)TH组和TL组骨骼肌和肝脏基础葡萄糖摄取量均明显高于C组(P<0.01),且TH组明显高于TL组(P<0.01)。3)TH组和TL组骨骼肌和肝脏胰岛素刺激的葡萄糖摄取量均明显低于C组(P<0.01),且TH组明显低于TL组(P<0.01)。4)T1组骨骼肌和肝脏无论基础还是胰岛素刺激的葡萄糖摄取量均与C组差异无显著性(P>0.05)。结论1)正常动物肝脏和骨骼肌葡萄糖摄取方式不同,骨骼肌葡萄糖摄取受胰岛素调控比肝脏强。2)TNFα抑制组织胰岛素刺激的葡萄糖摄取,但促进组织基础葡萄糖摄取。3)TNFα对组织葡萄糖摄取的影响,呈剂量和时间依赖性。     

肿瘤坏死因子致肺微血管内皮细胞单层通透性损伤的实验研究

目的和方法：用针头式滤器检测肿瘤坏死因子（TNF）作用前后及三种药物干预时大鼠肺微血管内皮细胞（RPMVEC）单层通透性的变化,并用免疫组化的方法检测TNF作用前后细胞F－肌动蛋白的改变。结果：TNF作用30min、60min、90min通透系数Kf值较致伤前显著增高;分别加福莫特罗（FOR）、山莨菪碱或霍乱毒素（CTX）干预时Kf值均显著低于TNF组。而TNF作用90min,RPMVEC F-肌动蛋白发生明显解聚：分别加POR、山莨菪硷或CTX干预时F－肌动蛋白无明显变化。结论：TNF诱导RPMVEC单层通透性增高的机制与细胞F－肌动蛋白解聚有关,FOR、山莨菪碱和CTX可能通过抑制F－肌动蛋白解聚而抑制NF诱导的RPMVEC单层通透性增高。     

Neuritin对大鼠急性脊髓损伤后神经中丝作用的研究

目的:探讨Neuritin对大鼠脊髓损伤后神经元突起再生的作用.方法:分为Neuritin组,His组和假手术组.使用改良Allen's打击法打击Neuritin组和His组大鼠T10或T11节段脊髓.Neuritin组和His组经蛛网膜下腔置管局部连续给予Neuritin和His蛋白(6ug/d)一周.假手术组仅咬除椎板不损伤脊髓,经蛛网膜下腔置空管而部损伤脊髓.术后6h、3d、7d、14d、28d、56d分别观察:①运动功能评分(BBB评分)观察大鼠后肢运动功能恢复情况;②HE染色观察脊髓组织形态学变化;③免疫组织化学染色和Western blotting检测损伤段脊髓神经中丝蛋白(NF200)的修复与再生.结果:①BBB评分,Neuritin组和His组在一周内没有明显差别,但Neuritin组和His组的评分均低于假手术组,从术后第14d,实验组评分明显高于对照组(P＜0.05);②HE染色可见损伤段脊髓出血、坏死及炎性细胞浸润;③免疫组化检测,Neuritin组的NF200平均光密度值(IOD/AREA)较His组明显增高(P＜0.05);Western blotting检测的NF200灰度值(GMD)较His组明显增高(P＜0.05),结论:持续外源性Neuritin能促进大鼠脊髓损伤后伤区神经元突起的再生,并能促进大鼠后肢运动功能的康复.     

AFP表达调控载体对肝癌模型的靶向治疗作用

目的观察甲胎蛋白(AFP)表达调控载体pAFP-P53-EGFP对AFP表达阳性肝癌模型靶向治疗作用。方法以人肝癌HepG2(AFP阳性)、人肝癌SMMC7721(AFP阴性)细胞于BALB/c-nu裸小鼠右腋皮下荷瘤,14d成瘤,免疫组化检测AFP。将构建好的pAFP-EGFP和pAFP-P53-EGFP重组质粒于肿瘤内注射,观察肿瘤体积变化,通过免疫组化观察p53在HepG2肿瘤中的特异性表达及对肿瘤细胞的杀伤作用。结果荷HepG2、SMMC7721细胞株裸鼠14d皮下肿瘤生长良好,且肿瘤体积均为500mm3左右,经HE染色证实造模成功。同时,AFP免疫组化结果显示接种HepG2细胞的肿瘤组织AFP表达阳性,SMMC7721细胞的肿瘤组织AFP表达为阴性。经pAFP-EGFP和pAFP-P53-EGFP重组质粒治疗后,p53的免疫组化分析结果显示接种HepG2细胞的裸鼠pAFP-P53-EGFP治疗组p53表达量显著高于其他各组,可见明显细胞凋亡现象,且肿瘤体积较对照组减小。结论含AFP基因调控序列的pAFP-P53-EGFP载体可专一性地作用于AFP阳性肝癌细胞,引起肝癌细胞周期阻滞和凋亡。     

饮水添加硼不影响乌鸡骨骼肌品质

目的明确饮水中添加硼对乌鸡骨骼肌品质的影响。方法1日龄乌鸡24羽,随机分成6组,每组4羽,饲喂相同的基础日粮及含不同浓度硼(0、40、80、160、320、640mg/L)的饮水,80d后,取乌鸡髂腓肌作为实验样品。用石蜡切片免疫组织化学检测骨骼肌Bcl-2表达;测定组织pH值、水分、灰分、粗蛋白、粗脂肪、剪切力、肉色及滴水损失。结果除在饲喂640mg/L乌鸡骨骼肌中,Bcl-2免疫组织化学表达上调,pH值、灰分显著性升高,粗蛋白含量显著性降低外,水分、粗脂肪、剪切力、肉色及滴水损失在各浓度饲喂乌鸡骨骼肌中均无明显差异。结论结果表明,乌鸡肌肉品质各项指标对饮水中硼的浓度不敏感,只有达到极高剂量(640mg/L)时才会使pH值、灰分、粗蛋白发生显著性变化,这些变化可能与骨骼肌细胞Bcl-2的表达有关。     

外胚间充质干细胞构建组织工程骨骼肌的应用研究

目的:探讨利用大鼠颌突外胚间充质干细胞构建组织工程骨骼肌的可行性,并观察对骨骼肌缺损的修复重建的促进效应。方法:取妊娠E 11.5胎鼠颌突外胚间充质干细胞,纯化后在含5ml/L体积浓度二甲基亚砜的DMEM/F12培养基中诱导分化为骨骼肌样细胞,将细胞种植于BAM膜上培养形成组织工程骨骼肌。将其移植入大鼠骨骼肌缺损模型,手术后14 d观察骨骼肌恢复情况,同期进行组织学及免疫组化染色鉴定。结果:经诱导后外胚间充质干细胞可向骨骼肌样细胞转化,构建的组织工程骨骼肌可加速缺损的修复重建,组织学染色显示外胚间充质干细胞具有正常骨骼肌的组织形态,可表达成肌相关蛋白MyOD。结论:诱导后的外胚间充质干细胞可作为种子细胞构建组织工程骨骼肌,本实验为临床肌肉的缺损修复奠定了理论基础。     

Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin

Trim32 belongs to the tripartite motif (TRIM) protein family, which is characterized by a common domain structure composed of a RING-finger, a B-box, and a coiled-coil motif. In addition to these motifs, Trim32 possesses six C-terminal NHL-domains. A point mutation in one NHL domain (D487N) has been linked to two forms of muscular dystrophy called limb girdle muscular dystrophy type 2H and sarcotubular myopathy. In the present study we demonstrate that Trim32 is an E3 ubiquitin ligase that acts in conjunction with ubiquitin-conjugating enzymes UbcH5a, UbcH5c, and UbcH6. Western blot analysis showed that Trim32 is expressed primarily in skeletal muscle, and revealed its differential expression from one muscle to another. The level of Trim32 expression was elevated significantly in muscle undergoing remodeling due to changes in weight bearing. Furthermore, expression of Trim32 was induced in myogenic differentiation. Thus, variability in Trim32 expression in different skeletal muscles could be due to induction of Trim32 expression upon changes in physiological conditions. We show that Trim32 associates with skeletal muscle thick filaments, interacting directly with the head and neck region of myosin. Our data indicate that myosin is not a substrate of Trim32; however, Trim32 was found to ubiquitinate actin in vitro and to cause a decrease in the level of endogenous actin when transfected into HEK293 cells. In conclusion, our results demonstrate that Trim32 is a ubiquitin ligase that is expressed in skeletal muscle, can be induced upon muscle unloading and reloading, associates with myofibrils and is able to ubiquitinate actin, suggesting its likely participation in myofibrillar protein turnover, especially during muscle adaptation.     

Correlation between polymerizability and conformation in scallop beta-like actin and rabbit skeletal muscle alpha-actin.

In order to investigate the structural basis for functional differences among actin isoforms, we have compared the polymerization properties and conformations of scallop adductor muscle beta-like actin and rabbit skeletal muscle alpha-actin. Polymerization of scallop Ca(2+)-actin was slower than that of skeletal muscle Ca(2+)-actin. Cleavage of the actin polypeptide chain between Gly-42 and Val-43 with Escherichia coli protease ECP 32 impaired the polymerization of scallop Mg(2+)-actin to a greater extent than skeletal muscle Mg(2+)-actin. When monomeric scallop and skeletal muscle Ca(2+)-actins were subjected to limited proteolysis with trypsin, subtilisin, or ECP 32, no differences in the conformation of actin subdomain 2 were detected. At the same time, local differences in the conformations of scallop and skeletal muscle actin subdomains 1 were revealed as intrinsic fluorescence differences. Replacement of tightly bound Ca(2+) with Mg(2+) resulted in more extensive proteolysis of segment 61-69 of scallop actin than in the case of skeletal muscle actin. Furthermore, segment 61-69 was more accessible to proteolysis with subtilisin in polymerized scallop Ca(2+)-actin than in polymerized skeletal muscle Ca(2+)-actin, indicating that, in the polymeric form, the nucleotide-containing cleft is in a more open conformation in beta-like scallop actin than in skeletal muscle alpha-actin. We suggest that this difference between scallop and skeletal muscle actins is due to a less efficient shift of scallop actin subdomain 2 to the position it has in the polymer. The possible consequences of amino acid substitutions in actin subdomain 1 in the allosteric regulation of the actin cleft, and hence in the different stabilities of polymers formed by different actins, are discussed.     

Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period

All four of the muscle actins (skeletal, cardiac, vascular, and enteric) in higher vertebrates show distinct expression patterns and display highly conserved amino acid sequences. While it is hypothesized that each of the muscle isoactins is specifically adapted to its respective tissue and that the minor variations among them have developmental and/or physiological relevance, the exact functional and developmental significance of these proteins remains largely unknown. In order to begin to assess these issues, we disrupted the skeletal actin gene by homologous recombination. All mice lacking skeletal actin die in the early neonatal period (day 1 to 9). These null animals appear normal at birth and can breathe, walk, and suckle, but within 4 days, they show a markedly lower body weight than normal littermates and many develop scoliosis. Null mice show a loss of glycogen and reduced brown fat that is consistent with malnutrition leading to death. Newborn skeletal muscles from null mice are similar to those of wild-type mice in size, fiber type, and ultrastructural organization. At birth, both hemizygous and homozygous null animals show an increase in cardiac and vascular actin mRNA in skeletal muscle, with no skeletal actin mRNA present in null mice. Adult hemizygous animals show an increased level of skeletal actin mRNA in hind limb muscle but no overt phenotype. Extensor digitorum longus (EDL) muscle isolated from skeletal-actin-deficient mice at day 2 to 3 showed a marked reduction in force production compared to that of control littermates, and EDL muscle from hemizygous animals displayed an intermediate force generation. Thus, while increases in cardiac and vascular smooth-muscle actin can partially compensate for the lack of skeletal actin in null mice, this is not sufficient to support adequate skeletal muscle growth and/or function.     

Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro.

We examined the expression of alpha-skeletal, alpha-cardiac, and beta- and gamma-cytoskeletal actin genes in a mouse skeletal muscle cell line (C2C12) during differentiation in vitro. Using isotype-specific cDNA probes, we showed that the alpha-skeletal actin mRNA pool reached only 15% of the level reached in adult skeletal muscle and required several days to attain this peak, which was then stably maintained. However, these cells accumulated a pool of alpha-cardiac actin six times higher than the alpha-skeletal actin mRNA peak within 24 h of the initiation of differentiation. After cells had been cultured for an additional 3 days, this pool declined to 10% of its peak level. In contrast, over 95% of the actin mRNA in adult skeletal muscle coded for alpha-actin. This suggests that C2C12 cells express a pattern of sarcomeric actin genes typical of either muscle development or regeneration and distinct from that seen in mature, adult tissue. Concurrently in the course of differentiation the beta- and gamma-cytoskeletal actin mRNA pools decreased to less than 10% of their levels in proliferating cells. The decreases in beta- and gamma-cytoskeletal actin mRNAs are apparently not coordinately regulated.     

Production of human skeletal alpha-actin proteins by the baculovirus expression system

Mutations within the human skeletal muscle alpha-actin gene cause three different skeletal muscle diseases. Functional studies of the mutant proteins are necessary to better understand the pathogenesis of these diseases, however, no satisfactory system for the expression of mutant muscle actin proteins has been available. We investigated the baculovirus expression vector system (BEVS) for the abundant production of both normal and mutant skeletal muscle alpha-actin. We show that non-mutated actin produced in the BEVS behaves similarly to native actin, as shown by DNase I affinity purification, Western blotting, and consecutive cycles of polymerisation and depolymerisation. Additionally, we demonstrate the production of mutant actin proteins in the BEVS, without detriment to the insect cells in which they are expressed. The BEVS therefore is the method of choice for studying mutant actin proteins causing human diseases.     

Expression of myostatin gene in regenerating skeletal muscle of the rat and its localization

The expression of myostatin mRNA was examined in regenerating skeletal muscle of the rat. Skeletal muscle regeneration was induced by injecting bupivacaine or hypertonic saline solution into the femoral muscle, and the tissues were collected 48 h after the treatment. In situ hybridization analysis revealed that the cells positive for myostatin message were localized in the regenerating area of the bupivacaine-treated tissues, where a numerous number of mononucleated cells were present. The myostatin-positive mononucleated cells contained both myogenic and nonmyogenic cells, as revealed by immunohistochemical staining for desmin and vimentin. Bupivacaine treatment to the testes resulted in no myostatin message expression in the testicular vimentin-positive cells, suggesting that the expression of myostatin message in vimentin-positive cells is a skeletal muscle-specific phenomenon. Furthermore, crushed muscle extract prepared from regenerating skeletal muscle had induced myostatin mRNA expression in skeletal muscle-derived fibroblasts in a dose-dependent manner. These results indicated that myostatin is expressed during skeletal muscle regeneration both in myogenic and nonmyogenic cells, and suggested that some factor(s) capable of inducing myostatin expression in fibroblasts are present in regenerating skeletal muscle.     

Novel application of flow cytometry: determination of muscle fiber types and protein levels in whole murine skeletal muscles and heart

Conventional methods for measuring proteins within muscle samples such as immunohistochemistry and western blot analysis can be time consuming, labor intensive and subject to sampling errors. We have developed flow cytometry techniques to detect proteins in whole murine heart and skeletal muscle. Flow cytometry and immunohistochemistry were performed on quadriceps and soleus muscles from male C57BL/6J, BALB/c, CBA and mdx mice. Proteins including actins, myosins, tropomyosin and alpha-actinin were detected via single staining flow cytometric analysis. This correlated with immunohistochemistry using the same antibodies. Muscle fiber types could be determined by dual labeled flow cytometry for skeletal muscle actin and different myosins. This showed similar results to immunohistochemistry for I, IIA and IIB myosins. Flow cytometry of heart samples from C57BL/6J and BALB/c mice dual labeled with cardiac and skeletal muscle actin antibodies demonstrated the known increase in skeletal actin protein in BALB/c hearts. The membrane-associated proteins alpha-sarcoglycan and dystrophin could be detected in C57BL/6J mice, but were decreased or absent in mdx mice. With the ability to label whole muscle samples simultaneously with multiple antibodies, flow cytometry may have advantages over conventional methods for certain applications, including assessing the efficacy of potential therapies for muscle diseases.     

At least six different actins are expressed in a higher mammal: An analysis based on the amino acid sequence of the amino-terminal tryptic peptide

The protein chemical characterization of the amino-terminal tryptic peptide of actin from different bovine tissues shows that at least six different actin structural genes are expressed in this mammal.Unique amirio acid sequences are found for actin from skeletal muscle, for actin from heart muscle, for two different actin species from smooth muscle, and for two different actin species typical of non-muscle tissues such as brain and thymus. The presence of more than one actin species in the same tissue (e.g. nonmuscle tissues and smooth muscles) is demonstrated by different amino-terminal peptides which, however, are closely related. The actins from the sarcomeric muscles (e.g. skeletal muscle and heart muscle) show unique but extremely similar amino-terminal peptides. A limited comparison of bovine and avian actins involving smooth and skeletal muscles emphasizes that among higher vertebrates actin divergence involves tissue rather than species specificity.For the lower eukaryotic organism Physarum polycephalum a single actin amino-terminal peptide is found, indicating that only one actin species is present during the plasmodial stage. The amino acid sequence of this peptide although unique reveals a high degree of homology with the corresponding mammalian cytoplasmic actin peptides.Different actin extraction and purification procedures have been compared by the relative yields of the different amino-terminal peptides. The results indicate that the various actin species obtained by the current purification procedures are a true reflection of the actual actins present in the tissue. In addition we compare the resolution provided by either isoelectric focusing analysis of different actins or by the protein chemical characterization of the amino-terminal peptides of different actins. We show that the latter procedure is more suitable for recording changes in actin expression during evolution and differentiation.     

Simultaneous expression of skeletal muscle and heart actin proteins in various striated muscle tissues and cells. A quantitative determination of the two actin isoforms

A procedure was developed to determine the percentage of skeletal muscle actin and cardiac actin present in different striated muscle tissues. The method was applied to 2 mg of actin mixtures isolated from various origins. All samples show simultaneous expression of both striated muscle isoactins, with the cardiac actin being the major form (congruent to 80%) in 11-day-old chick embryonic leg muscle, decreasing to approximately 50% values in the late fetal stage of chicken, mouse, and in fused mouse muscle cell cultures and becoming the minor species (less than 5%) in adult skeletal muscle tissues. We also find a significant amount (up to 20%) of the skeletal muscle isoform in adult heart (ventricle) of porcine, bovine, and human origin and no differences in muscle actin ratios in human atrium and ventriculum cells. Similarly, no significant variation in the actin ratios was observed between a normal heart and a heart from a patient with hereditary obstructive myopathy. For those cells and tissues where comparison with levels of mRNA was possible we mostly find a good correlation between the relative ratios of expression of cardiac and skeletal actin proteins and mRNAs.